Navigation Links
Ash Stevens Plans $6 Million Facility Expansion to Bolster CMC Capabilities
Date:9/30/2009

Ash Stevens, Incorporated (ASI), a full service contract drug development and cGMP manufacturer, announced that the company is in the initial phases of a multi-year $6 million expansion project to upgrade the capacity and capabilities of its Active Pharmaceutical Ingredient (API) manufacturing facility located in Riverview, Michigan. Expansions will include a new reactor bay and warehouse.

Detroit, MI (PRWEB) September 30, 2009 -- Ash Stevens, Incorporated (ASI), a full service contract drug development and cGMP manufacturer, announced that the company is in the initial phases of a multi-year expansion project to upgrade the capacity and capabilities of its Active Pharmaceutical Ingredient (API) manufacturing facility located in Riverview, Michigan. Expenditures for the initial phases of the project will total more than $6 million and will include a new reactor bay and warehouse. The investment will add significant capacity and additional capabilities to the existing ASI facility as part of ASI's on-going commitment to provide the company's clients with the highest quality of service, safety, and on-time delivery of APIs.

To be operational in January 2010, the plan's initial phase calls for an isolated new reactor bay, which will house two 100-gallon glass-lined reactors and a 50-gallon hydrogenation vessel. The new reactor bay will provide redundant capacity to a similarly designed existing bay that holds three 100-gallon reactors, while providing additional plant capacity and plant-scale hydrogenation capabilities.

In June of 2010, ASI will occupy a new 10,000 square foot warehouse facility. Completion of the state-of-the-art reactor bay and warehouse facility will set the stage for execution of the next phases of the expansion plan.

"The new bay and warehouse represent a self-financed $6 million investment for ASI. The continuous upgrading and modernization of our operations is an essential component of our business model to provide our clients the highest quality of service while ensuring delivery of their API on time and on schedule from a safe and environmentally friendly facility. As we increase our efficiencies with larger equipment, we also enhance our cost-effectiveness, further benefiting our customers," said Dr. Stephen Munk, President and CEO of Ash Stevens.

Subsequent phases of the expansion plan call for a new large-scale reactor bay, process development labs, and additional facilities to handle highly potent APIs.

For more information, visit Ash Stevens at CPhI Worldwide in Madrid, Spain, booth #NB403 located in the New Business Pavillion on October 16-19, 2009 or online at www.ashstevens.com. James M. Hamby, R.Ph., Ph.D., Vice President of Business Development for Ash Stevens, Inc. will be speaking on the topic of Managing CMC Development for FDA Fast-Tracked Drugs on Tuesday, October 13 at 2:00 p.m.

About Ash Stevens, Inc.
Headquartered in Detroit, Ash Stevens, Inc. (ASI) was founded in 1962 to service the chemical research needs of the Federal Government. ASI has extensive experience in the development and scale-up of commercial cancer APIs and shares a longstanding and successful relationship with the National Cancer Institute. ASI has a total of 11 FDA approved drug substances in its portfolio. The company has more than 60 employees and holds a variety of patents covering topics including medicinal agents and manufacturing processes. For more information, visit www.ashstevens.com.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2966284.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
2. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
3. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
4. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus
5. Stevens researchers provide new information about mass spectrometry
6. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
7. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
8. Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
9. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
10. Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.
11. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/9/2017)... ... 09, 2017 , ... The Giving Tree Wellness Center announces ... needs of consumers who are incorporating medical marijuana into their wellness and health ... As operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach ...
(Date:10/7/2017)... , ... October 06, 2017 ... ... in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring ... kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using ...
(Date:10/6/2017)... ... October 06, 2017 , ... On ... and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). The ... The event is free and open to the public, but registration is required. ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):